adenocarcinoma


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
?Note: This page may contain content that is offensive or inappropriate for some readers.

ad·e·no·car·ci·no·ma

 (ăd′n-ō-kär′sə-nō′mə)
n.
A malignant tumor originating in glandular tissue.

ad′e·no·car′ci·nom′a·tous (-nŏm′ə-təs, -nō′mə-təs) adj.

adenocarcinoma

(ˌædɪnəʊˌkɑːsɪˈnəʊmə)
n, pl -mas or -mata (-mətə)
1. (Pathology) a malignant tumour originating in glandular tissue
2. (Pathology) a malignant tumour with a glandlike structure

ad•e•no•car•ci•no•ma

(ˌæd n oʊˌkɑr səˈnoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
1. a malignant tumor arising from secretory epithelium.
2. a malignant tumor of glandlike structure.
[1885–90]
ad`e•no•car`ci•nom′a•tous (-ˈnɒm ə təs, -ˈnoʊ mə-) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.adenocarcinoma - malignant tumor originating in glandular epitheliumadenocarcinoma - malignant tumor originating in glandular epithelium
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
prostate cancer, prostatic adenocarcinoma - cancer of the prostate gland
Translations

ad·e·no·car·ci·no·ma

n. adenocarcinoma, cáncer maligno que se origina en una glándula.

adenocarcinoma

n adenocarcinoma m
References in periodicals archive ?
Therefore, even though in our case the biopsy suggested adenocarcinoma, after resection and complex assessment of the surgical specimen a final diagnosis of mixed adenoneuroendocrine tumor was made.
In this case report, we describe the classical morphologic features of a pulmonary papillary adenocarcinoma which resemble those of papillary thyroid carcinoma and discuss the utility of immunohistochemical staining in distinguishing primary from metastatic tumours.
Primary mucinous adenocarcinoma can arise throughout the body, the most common sites being the head and the neck.
The training set resulted in a 50-gene index that identified low-risk and high-risk stage I lung adenocarcinoma subgroups that differed substantially with respect to survival and that was validated in the independent set.
Presently, routine testing for HER-2 protein overexpression in gastric or oesophageal adenocarcinoma does not occur in Ghana.
In this study, we aimed to identify and characterize differentially expressed lncRNAs in lung adenocarcinoma. TCGA analysis showed that SNHG3 was significantly upregulated in lung adenocarcinoma.
Histology showed anal adenocarcinoma with mucosecreting component and independent cells (Figure 2).
Histologic findings were those of a carcinosarcoma with endometrioid adenocarcinoma (20%), hepatoid adenocarcinoma (20%), and sarcomatous components consisting of chondroid (10%) and spindle cell components (50%) [Figure 4].
Material and Methods: All specimens of adenocarcinoma prostate diagnosed at Armed forces institute of pathology on the basis of immunohistochemistry and routine histopathology irrespective of age of patient, histological type or grade of the tumor were analyzed.
Henrikson, Ph.D., M.P.H., from the Kaiser Permanente Washington Health Research Institute in Seattle, and colleagues conducted a systematic review of the benefits and harms of screening for pancreatic adenocarcinoma to inform the USPSTF.
Just like in Her2/neu positive breast cancer, Trastuzumab (Herceptin) is also effective in Her2-positive gastric adenocarcinoma and is approved, in combination with chemotherapy, in the international phase III Trastuzumab for Gastric Cancer (ToGA) trial.5 It can be continued as monotherapy in patients with chemotherapeutic adverse reactions.3 The frequency of HER2-positive gastric cancer varies from 6% to 29.5%.3 The status of HER2/neu expression can be evaluated both on endoscopic biopsies or resection specimens using immunohistochemistory (IHC) or fluorescence in situ hybridisation (FISH).3 The current study was planned to determine HER/neu overexpression in gastric adenocarcinomas using IHC in a tertiary care setup.